GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Arzneiwerk AG VIDA (LTS:0NKY) » Definitions » Profitability Rank

Arzneiwerk AG VIDA (LTS:0NKY) Profitability Rank : 3 (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Arzneiwerk AG VIDA Profitability Rank?

Arzneiwerk AG VIDA has the Profitability Rank of 3. It has had trouble to make a profit.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Arzneiwerk AG VIDA's Operating Margin % for the quarter that ended in Jun. 2024 was -1.04%. As of today, Arzneiwerk AG VIDA's Piotroski F-Score is 6.


Competitive Comparison of Arzneiwerk AG VIDA's Profitability Rank

For the Medical Distribution subindustry, Arzneiwerk AG VIDA's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arzneiwerk AG VIDA's Profitability Rank Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arzneiwerk AG VIDA's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Arzneiwerk AG VIDA's Profitability Rank falls into.



Arzneiwerk AG VIDA Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Arzneiwerk AG VIDA has the Profitability Rank of 3. It has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Arzneiwerk AG VIDA's Operating Margin % for the quarter that ended in Jun. 2024 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=-0.151 / 14.517
=-1.04 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Arzneiwerk AG VIDA has an F-score of 6 indicating the company's financial situation is typical for a stable company.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Arzneiwerk AG VIDA Profitability Rank Related Terms

Thank you for viewing the detailed overview of Arzneiwerk AG VIDA's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Arzneiwerk AG VIDA Business Description

Traded in Other Exchanges
Address
Ordensmeisterstrasse 15-16, Berlin, DEU, 12099
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe which usually includes high-priced drugs for chronic, complex, or rare diseases such as oncology, neurology, autoimmune diseases, ophthalmology, hemophilia, and infectious diseases.

Arzneiwerk AG VIDA Headlines

No Headlines